{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T05:46:00Z","timestamp":1782798360949,"version":"3.54.5"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>A greater understanding of gestational age-adjusted steroid profiles in preterm neonates is needed to inform diagnosis, optimal timing, dosage, and duration of postnatal steroid therapy for preterm infants with adrenal insufficiency. Therefore, we evaluated changes in steroid profiles using newborn screening dried blood spots (DBS) to determine the impact of prematurity on fetal adrenal function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Cortisol and its biosynthetic precursors were quantified in 813 anonymized DBS from newborns between 23 to 42 weeks of gestation, collected within 72\u2009hours of birth and again approximately two weeks later. Steroid quantification was performed using liquid chromatography-tandem mass spectrometry (LC-MS\/MS), with analyses stratified by gestational and postnatal ages.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Extremely preterm infants often had elevated cortisol levels, with a general decline as gestational age increased. Levels of 17-hydroxyprogesterone (17OHP4) and corticosterone were significantly higher in most preterm newborns, with 17OHP4 showing the strongest inverse correlation with gestational age. In contrast, aldosterone levels remained unaffected by gestational age.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Elevations in 17OHP4 and corticosterone, rather than cortisol alone, reflect prematurity\u2019s effect on adrenal sufficiency. Preterm infants with high cortisol and elevated corticosterone and 17OHP4 levels may struggle to meet their physiological cortisol needs through the hypothalamic-pituitary-adrenal axis, increasing the risk of adrenal crises. These findings provide important insights to guide the management of adrenal insufficiency in preterm neonates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Impact<\/jats:title>\n                    <jats:p>The increasing survival of preterm infants born at earlier gestational ages presents clinicians with the complex challenge of distinguishing normal from abnormal adrenal function, a determination which may be critical for survival. Our study advances the understanding of adrenal dysfunction in this population by employing analytical methods rooted in the steroid biosynthesis pathway\u2019s maturation. By utilizing techniques traditionally used to diagnose congenital adrenal hyperplasia (CAH), we provide actionable guidance for interpreting steroid data in preterm infants, offering a practical framework for improved clinical decision-making.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41390-025-04216-5","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T16:45:35Z","timestamp":1754585135000},"page":"1085-1095","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Elevation of corticosterone and 17OH progesterone in extremely preterm infants and clinical implications"],"prefix":"10.1038","volume":"99","author":[{"given":"Julie M.","family":"Kessel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice K.","family":"Held","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric R.","family":"Bialk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan M.","family":"McAdams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian M.","family":"Bird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"key":"4216_CR1","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1210\/jcem.82.8.4152","volume":"82","author":"PC Ng","year":"1997","unstructured":"Ng, P. C. et al. Pituitary-adrenal suppression and recovery in preterm very low birth weight infants after dexamethasone treatment for bronchopulmonary dysplasia. J. Clin. Endocrinol. Metab. 82, 2429\u20132432 (1997).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4216_CR2","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00431-002-0986-9","volume":"161","author":"E Mildenberger","year":"2002","unstructured":"Mildenberger, E. & Versmold, H. T. Pathogenesis and therapy of non-oliguric hyperkalaemia of the premature infant. Eur. J. Pediatr. 161, 415\u2013422 (2002).","journal-title":"Eur. J. Pediatr."},{"key":"4216_CR3","doi-asserted-by":"publisher","first-page":"e475","DOI":"10.1542\/neo.16-8-e474","volume":"16","author":"ME Weiss","year":"2015","unstructured":"Weiss, M.E., Caldarelli, L., Hageman, J.R., & Littlejohn, E. Relative adrenal insufficiency in premature infants: state of the art. NeoReviews 16, e475\u2013480 (2015).","journal-title":"NeoReviews"},{"key":"4216_CR4","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1038\/jp.2009.24","volume":"29","author":"EF Fernandez","year":"2009","unstructured":"Fernandez, E. F. & Watterberg, K. L. Relative adrenal insufficiency in the preterm and term infant. J. Perinatol. 29, S44\u2013S49 (2009).","journal-title":"J. Perinatol."},{"key":"4216_CR5","doi-asserted-by":"publisher","first-page":"F119","DOI":"10.1136\/adc.2002.021972","volume":"89","author":"PC Ng","year":"2004","unstructured":"Ng, P. C. et al. Transient adrenocortical insufficiency of prematurity and systemic hypotension in very low birthweight infants. Arch. Dis. Child Fetal Neonatal Ed 89, F119\u2013F126 (2004).","journal-title":"Arch. Dis. Child Fetal Neonatal Ed"},{"key":"4216_CR6","doi-asserted-by":"crossref","unstructured":"Watterberg, K. Vol. 7 e135-e142 (NeoReviews, 2006).","DOI":"10.1542\/neo.7-3-e135"},{"key":"4216_CR7","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.pedneo.2019.09.005","volume":"60","author":"S Iijima","year":"2019","unstructured":"Iijima, S. Late-onset glucocorticoid-responsive circulatory collapse in premature infants. Pediatr. Neonatol. 60, 603\u2013610 (2019).","journal-title":"Pediatr. Neonatol."},{"key":"4216_CR8","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.pedneo.2018.12.001","volume":"60","author":"K Masumoto","year":"2019","unstructured":"Masumoto, K., Tagawa, N., Kobayashi, Y. & Kusuda, S. Cortisol production in preterm infants with or without late-onset adrenal insufficiency of prematurity: a prospective observational study. Pediatr. Neonatol. 60, 504\u2013511 (2019).","journal-title":"Pediatr. Neonatol."},{"key":"4216_CR9","first-page":"266","volume":"78","author":"RV Hingre","year":"1994","unstructured":"Hingre, R. V., Gross, S. J., Hingre, K. S., Mayes, D. M. & Richman, R. A. Adrenal steroidogenesis in very low birth weight preterm infants. J. Clin. Endocrinol. Metab. 78, 266\u2013270 (1994).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4216_CR10","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0022-3476(96)70404-3","volume":"128","author":"C Korte","year":"1996","unstructured":"Korte, C. et al. Adrenocortical function in the very low birth weight infant: improved testing sensitivity and association with neonatal outcome. J. Pediatr. 128, 257\u2013263 (1996).","journal-title":"J. Pediatr."},{"key":"4216_CR11","doi-asserted-by":"publisher","first-page":"4621","DOI":"10.1210\/jc.2001-011620","volume":"87","author":"PC Ng","year":"2002","unstructured":"Ng, P. C. et al. Reference ranges and factors affecting the human corticotropin-releasing hormone test in preterm, very low birth weight infants. J. Clin. Endocrinol. Metab. 87, 4621\u20134628 (2002).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4216_CR12","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.pedneo.2019.03.003","volume":"60","author":"JH Hwang","year":"2019","unstructured":"Hwang, J. H. et al. Basal serum cortisol concentration in very low birth weight infants. Pediatr. Neonatol. 60, 648\u2013653 (2019).","journal-title":"Pediatr. Neonatol."},{"key":"4216_CR13","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/S0022-3476(95)70229-6","volume":"126","author":"S al Saedi","year":"1995","unstructured":"al Saedi, S., Dean, H., Dent, W. & Cronin, C. Reference ranges for serum cortisol and 17-hydroxyprogesterone levels in preterm infants. J. Pediatr. 126, 985\u2013987 (1995).","journal-title":"J. Pediatr."},{"key":"4216_CR14","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1210\/jcem-69-6-1133","volume":"69","author":"MM Lee","year":"1989","unstructured":"Lee, M. M., Rajagopalan, L., Berg, G. J. & Moshang, T. Serum adrenal steroid concentrations in premature infants. J. Clin. Endocrinol. Metab. 69, 1133\u20131136 (1989).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4216_CR15","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/jp.2009.191","volume":"30","author":"SW Aucott","year":"2010","unstructured":"Aucott, S. W. et al. Early cortisol values and long-term outcomes in extremely low birth weight infants. J. Perinatol. 30, 484\u2013488 (2010).","journal-title":"J. Perinatol."},{"key":"4216_CR16","first-page":"1659","volume":"4","author":"K Seshagiri","year":"2017","unstructured":"Seshagiri, K. & Venkata, H. Y. Cortisol levels in healthy term and preterm appropriate for gestation infants. Int. J. Contemp. Med. Res. 4, 1659\u20131664 (2017).","journal-title":"Int. J. Contemp. Med. Res."},{"key":"4216_CR17","first-page":"378","volume":"18","author":"S Mesiano","year":"1997","unstructured":"Mesiano, S. & Jaffe, R. B. Developmental and functional biology of the primate fetal adrenal cortex. Endocr. Rev. 18, 378\u2013403 (1997).","journal-title":"Endocr. Rev."},{"key":"4216_CR18","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1055\/s-2004-861549","volume":"22","author":"WE Rainey","year":"2004","unstructured":"Rainey, W. E., Rehman, K. S. & Carr, B. R. The human fetal adrenal: making adrenal androgens for placental estrogens. Semin Reprod. Med 22, 327\u2013336 (2004).","journal-title":"Semin Reprod. Med"},{"key":"4216_CR19","doi-asserted-by":"publisher","first-page":"5393","DOI":"10.1210\/jc.2005-0680","volume":"90","author":"R Sirianni","year":"2005","unstructured":"Sirianni, R., Mayhew, B. A., Carr, B. R., Parker, C. R. Jr & Rainey, W. E. Corticotropin-releasing hormone (CRH) and urocortin act through type 1 CRH receptors to stimulate dehydroepiandrosterone sulfate production in human fetal adrenal cells. J. Clin. Endocrinol. Metab. 90, 5393\u20135400 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4216_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-018-1009-7","volume":"16","author":"ZC Johnston","year":"2018","unstructured":"Johnston, Z. C. et al. The human fetal adrenal produces cortisol but no detectable aldosterone throughout the second trimester. BMC Med 16, 23 (2018).","journal-title":"BMC Med"},{"key":"4216_CR21","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1095\/biolreprod56.4.789","volume":"56","author":"AJ Conley","year":"1997","unstructured":"Conley, A. J. & Bird, I. M. The role of cytochrome P450 17 alpha-hydroxylase and 3 beta-hydroxysteroid dehydrogenase in the integration of gonadal and adrenal steroidogenesis via the delta 5 and delta 4 pathways of steroidogenesis in mammals. Biol. Reprod. 56, 789\u2013799 (1997).","journal-title":"Biol. Reprod."},{"key":"4216_CR22","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1210\/jc.2018-01759","volume":"104","author":"C Melau","year":"2019","unstructured":"Melau, C. et al. Characterization of human adrenal steroidogenesis during fetal development. J. Clin. Endocrinol. Metab. 104, 1802\u20131812 (2019).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4216_CR23","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1210\/er.2010-0001","volume":"32","author":"H Ishimoto","year":"2011","unstructured":"Ishimoto, H. & Jaffe, R. B. Development and function of the human fetal adrenal cortex: a key component in the feto-placental unit. Endocr. Rev. 32, 317\u2013355 (2011).","journal-title":"Endocr. Rev."},{"key":"4216_CR24","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3390\/ijns6030067","volume":"6","author":"PK Held","year":"2020","unstructured":"Held, P. K., Bird, I. M. & Heather, N. L. Newborn screening for congenital adrenal hyperplasia: review of factors affecting screening accuracy. Int J. Neonatal Screen 6, 67 (2020).","journal-title":"Int J. Neonatal Screen"},{"key":"4216_CR25","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1210\/jcem.82.3.3832","volume":"82","author":"PC Ng","year":"1997","unstructured":"Ng, P. C. et al. The pituitary-adrenal responses to exogenous human corticotropin-releasing hormone in preterm, very low birth weight infants. J. Clin. Endocrinol. Metab. 82, 797\u2013799 (1997).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4216_CR26","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1080\/17446651.2017.1356222","volume":"12","author":"MA Howland","year":"2017","unstructured":"Howland, M. A., Sandman, C. A. & Glynn, L. M. Developmental origins of the human hypothalamic-pituitary-adrenal axis. Expert Rev. Endocrinol. Metab. 12, 321\u2013339 (2017).","journal-title":"Expert Rev. Endocrinol. Metab."},{"key":"4216_CR27","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1097\/MOP.0000000000000414","volume":"28","author":"M Almannai","year":"2016","unstructured":"Almannai, M., Marom, R. & Sutton, V. R. Newborn screening: a review of history, recent advancements, and future perspectives in the era of next generation sequencing. Curr. Opin. Pediatr. 28, 694\u2013699 (2016).","journal-title":"Curr. Opin. Pediatr."},{"key":"4216_CR28","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1053\/j.semperi.2015.03.002","volume":"39","author":"BL Therrell","year":"2015","unstructured":"Therrell, B. L. et al. Current status of newborn screening worldwide: 2015. Semin. Perinatol. 39, 171\u2013187 (2015).","journal-title":"Semin. Perinatol."},{"key":"4216_CR29","doi-asserted-by":"publisher","first-page":"e20190290","DOI":"10.1542\/peds.2019-0290","volume":"144","author":"DC Kaluarachchi","year":"2019","unstructured":"Kaluarachchi, D. C., Allen, D. B., Eickhoff, J. C., Dawe, S. J. & Baker, M. W. Thyroid-stimulating hormone reference ranges for preterm infants. Pediatrics 144, e20190290 (2019).","journal-title":"Pediatrics"},{"key":"4216_CR30","doi-asserted-by":"publisher","first-page":"e3390","DOI":"10.1210\/clinem\/dgab383","volume":"106","author":"MR de Hora","year":"2021","unstructured":"de Hora, M. R., Heather, N. L., Webster, D., Albert, B. B. & Hofman, P. L. Birth weight- or gestational age-adjusted second-tier LCMSMS cutoffs improve newborn screening for CAH in New Zealand. J. Clin. Endocrinol. Metab. 106, e3390\u2013e3399 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4216_CR31","doi-asserted-by":"publisher","first-page":"3904","DOI":"10.1210\/jc.2004-2136","volume":"90","author":"HJ van der Kamp","year":"2005","unstructured":"van der Kamp, H. J. et al. Cutoff Levels of 17-alpha-hydroxyprogesterone in neonatal screening for congenital adrenal hyperplasia should be based on gestational age rather than on birth weight. J. Clin. Endocrinol. Metab. 90, 3904\u20133907 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4216_CR32","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1210\/jc.2006-2890","volume":"92","author":"N Janzen","year":"2007","unstructured":"Janzen, N. et al. Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry. J. Clin. Endocrinol. Metab. 92, 2581\u20132589 (2007).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4216_CR33","doi-asserted-by":"publisher","first-page":"e4487","DOI":"10.1210\/clinem\/dgab464","volume":"106","author":"K Stroek","year":"2021","unstructured":"Stroek, K. et al. Second-tier testing for 21-hydroxylase deficiency in the Netherlands: A newborn screening pilot study. J. Clin. Endocrinol. Metab. 106, e4487\u2013e4496 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4216_CR34","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jpeds.2020.12.057","volume":"234","author":"C Renolleau","year":"2021","unstructured":"Renolleau, C. et al. Association between baseline cortisol serum concentrations and the effect of prophylactic hydrocortisone in extremely preterm infants. J. Pediatr. 234, 65\u201370.e63 (2021).","journal-title":"J. Pediatr."},{"key":"4216_CR35","doi-asserted-by":"publisher","first-page":"F143","DOI":"10.1136\/archdischild-2016-312457","volume":"103","author":"S Travers","year":"2018","unstructured":"Travers, S., Martinerie, L., Boileau, P., Lomb\u00e8s, M. & Pussard, E. Alterations of adrenal steroidomic profiles in preterm infants at birth. Arch. Dis. Child Fetal Neonatal Ed. 103, F143\u2013F151 (2018).","journal-title":"Arch. Dis. Child Fetal Neonatal Ed."},{"key":"4216_CR36","doi-asserted-by":"publisher","first-page":"e3725","DOI":"10.1210\/clinem\/dgab194","volume":"106","author":"J Ruhnau","year":"2021","unstructured":"Ruhnau, J. et al. Impact of gestational and postmenstrual age on excretion of fetal zone steroids in preterm infants determined by gas chromatography-mass spectrometry. J. Clin. Endocrinol. Metab. 106, e3725\u2013e3738 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4216_CR37","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.1210\/clinem\/dgac482","volume":"107","author":"CE Fl\u00fcck","year":"2022","unstructured":"Fl\u00fcck, C. E., Kuiri-H\u00e4nninen, T., Silvennoinen, S., Sankilampi, U. & Groessl, M. The androgen metabolome of preterm infants reflects fetal adrenal gland involution. J. Clin. Endocrinol. Metab. 107, 3111\u20133119 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4216_CR38","doi-asserted-by":"publisher","first-page":"375","DOI":"10.4155\/bio.16.6","volume":"8","author":"A Boelen","year":"2016","unstructured":"Boelen, A., Ruiter, A. F., Claahsen-van der Grinten, H. L., Endert, E. & Ackermans, M. T. Determination of a steroid profile in heel prick blood using LC-MS\/MS. Bioanalysis 8, 375\u2013384 (2016).","journal-title":"Bioanalysis"},{"key":"4216_CR39","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1038\/s41390-023-02690-3","volume":"94","author":"M Romijn","year":"2023","unstructured":"Romijn, M. et al. Glucocorticoid signature of preterm infants developing bronchopulmonary dysplasia. Pediatr. Res 94, 1804\u20131809 (2023).","journal-title":"Pediatr. Res"},{"key":"4216_CR40","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/j.1476-5381.1990.tb12993.x","volume":"99","author":"Lightly","year":"1990","unstructured":"Lightly et al. Subclassification of beta-adrenoceptors responsible for steroidogenesis in primary cultures of bovine adrenocortisal zona fasiculata\/reticularis cells. Br. J. Pharmacol. 99, 709\u2013712 (1990).","journal-title":"Br. J. Pharmacol."},{"key":"4216_CR41","first-page":"501","volume":"180","author":"Charlton","year":"1992","unstructured":"Charlton et al. Noradrenergic innervation of the human adrenal cortex as revealed by dopamine-beta-hydroxylase immunohistochemistry. J. Anat. 180, 501\u2013506 (1992).","journal-title":"J. Anat."},{"key":"4216_CR42","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1203\/00006450-200011000-00013","volume":"48","author":"MW Huysman","year":"2000","unstructured":"Huysman, M. W., Hokken-Koelega, A. C., De Ridder, M. A. & Sauer, P. J. Adrenal function in sick very preterm infants. Pediatr. Res 48, 629\u2013633 (2000).","journal-title":"Pediatr. Res"},{"key":"4216_CR43","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1542\/peds.2004-1159","volume":"114","author":"KL Watterberg","year":"2004","unstructured":"Watterberg, K. L. et al. Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial. Pediatrics 114, 1649\u20131657 (2004).","journal-title":"Pediatrics"},{"key":"4216_CR44","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/jp.2017.68","volume":"37","author":"ES Peeples","year":"2017","unstructured":"Peeples, E. S. An evaluation of hydrocortisone dosing for neonatal refractory hypotension. J. Perinatol. 37, 943\u2013946 (2017).","journal-title":"J. Perinatol."},{"key":"4216_CR45","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1530\/JOE-11-0372","volume":"213","author":"PJ Fuller","year":"2012","unstructured":"Fuller, P. J., Yao, Y., Yang, J. & Young, M. J. Mechanisms of ligand specificity of the mineralocorticoid receptor. J. Endocrinol. 213, 15\u201324 (2012).","journal-title":"J. Endocrinol."},{"key":"4216_CR46","doi-asserted-by":"publisher","first-page":"4074","DOI":"10.1210\/jc.2015-2272","volume":"100","author":"L Martinerie","year":"2015","unstructured":"Martinerie, L. et al. Aldosterone-signaling defect exacerbates sodium wasting in very preterm neonates: The Premaldo study. J. Clin. Endocrinol. Metab. 100, 4074\u20134081 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4216_CR47","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1203\/PDR.0b013e3181b1bbec","volume":"66","author":"L Martinerie","year":"2009","unstructured":"Martinerie, L. et al. Physiological partial aldosterone resistance in human newborns. Pediatr. Res 66, 323\u2013328 (2009).","journal-title":"Pediatr. Res"},{"key":"4216_CR48","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1177\/1933719108324140","volume":"16","author":"JM Kessel","year":"2009","unstructured":"Kessel, J. M. et al. Antenatal betamethasone depresses maternal and fetal aldosterone levels. Reprod. Sci. 16, 94\u2013104 (2009).","journal-title":"Reprod. Sci."},{"key":"4216_CR49","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1001\/jama.2015.10244","volume":"314","author":"BJ Stoll","year":"2015","unstructured":"Stoll, B. J. et al. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993\u20132012. JAMA 314, 1039\u20131051 (2015).","journal-title":"JAMA"},{"key":"4216_CR50","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1177\/107155760000700501","volume":"7","author":"HH Kay","year":"2000","unstructured":"Kay, H. H., Bird, I. M., Coe, C. L. & Dudley, D. J. Antenatal steroid treatment and adverse fetal effects: what is the evidence? J. Soc. Gynecol. Investig. 7, 269\u2013278 (2000).","journal-title":"J. Soc. Gynecol. Investig."},{"key":"4216_CR51","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1203\/00006450-198002000-00011","volume":"14","author":"PL Ballard","year":"1980","unstructured":"Ballard, P. L., Gluckman, P. D., Liggins, G. C., Kaplan, S. L. & Grumbach, M. M. Steroid and growth hormone levels in premature infants after prenatal betamethasone therapy to prevent respiratory distress syndrome. Pediatr. Res 14, 122\u2013127 (1980).","journal-title":"Pediatr. Res"},{"key":"4216_CR52","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0378-3782(97)00037-6","volume":"49","author":"S Nomura","year":"1997","unstructured":"Nomura, S. Immature adrenal steroidogenesis in preterm infants. Early Hum. Dev. 49, 225\u2013233 (1997).","journal-title":"Early Hum. Dev."},{"key":"4216_CR53","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/j.jchromb.2011.03.048","volume":"879","author":"P Magnisali","year":"2011","unstructured":"Magnisali, P. et al. Simultaneous quantification of 17alpha-OH progesterone, 11-deoxycortisol, delta 4-androstenedione, cortisol and cortisone in newborn blood spots using liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 879, 1565\u20131572 (2011).","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"4216_CR54","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3343\/alm.2019.39.3.263","volume":"39","author":"R Choi","year":"2019","unstructured":"Choi, R. et al. Dried blood spot multiplexed steroid profiling using liquid chromatography tandem mass spectrometry in Korean neonates. Ann. Lab Med 39, 263\u2013270 (2019).","journal-title":"Ann. Lab Med"},{"key":"4216_CR55","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jpeds.2021.10.063","volume":"242","author":"PK Held","year":"2021","unstructured":"Held, P. K., Bialk, E. R., Lasarev, M. R. & Allen, D. B. 21-Deoxycortisol is a key screening marker for 21-hydroxylase deficiency. J. Pediatr. 242, 213\u2013219 (2021).","journal-title":"J. Pediatr."},{"key":"4216_CR56","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41390-021-01739-5","volume":"92","author":"OE Enver","year":"2024","unstructured":"Enver, O. E. et al. Adrenal steroids reference ranges in infancy determined by LC-MS\/MS. Pediatr. Res. 92, 265\u2013274 (2024).","journal-title":"Pediatr. Res."},{"key":"4216_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-024-03756-6","author":"O Baud","year":"2024","unstructured":"Baud, O., Toirchin, H., Butin, M., Flamant, C. & Nuytten, A. Prophylactic low-dose hydrocortisone in neonates born extremely preterm: current knowledge and future challenges. Pediatr. Res. https:\/\/doi.org\/10.1038\/s41390-024-03756-6 (2024).","journal-title":"Pediatr. Res."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04216-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04216-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04216-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T13:08:46Z","timestamp":1774530526000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04216-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4216"],"URL":"https:\/\/doi.org\/10.1038\/s41390-025-04216-5","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,7]]},"assertion":[{"value":"8 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}